OMOLOGICAL AND HETEROLOGICAL ANTIBODY AND T CELL IMMUNE RESPONSES TO LIVE ATTENUATED INFLUENZA VACCINE A (H5N2) AND A (H7N3)

From the beginning of 21th century outbreaks of H5, H7 and H9 avian flu are registered from time to time. These viruses are considered as one of the possible causes of the next pandemia. The development of avian influenza vaccines is one of the WHO priorities. The aim of this work was to study antibody and cellular immune responses to avian A (H5N2) and A (H7N3) live attenuated influenza vaccines (LAIVs). We examined serum antibodies (HAI assay, microneutralization assay, ELISA), local antibodies (ELISA) and virus-specific CD4+ and CD8+ central memory and effector memory T cells. Two doses vaccination of healthy volunteers with A (H5N2) and A (H7N3) LAIVs induced homological antibody and cellular immune responses (i. e. serum and local antibody conversions, virus-specific memory T cell growth). These vaccines also stimulated heterological immunity (heterological serum and local antibodies and T cells). Heterological immune response intensity depended on antigenic structure of vaccine strain and heterological virus, particularly on HA type. 

1. Донина С.А., Петухова Г.Д., Кореньков Д.А., Григорьева Е.П., Кузнецова С.А., Лосев И.В., Руденко Л.Г., Найхин А.Н. Локальный и гуморальный иммунный ответ у больных гриппом и у лиц, привитых против сезонных и пандемических вирусов гриппа А // Вопросы вирусологии, 2013. Т. 58, No 3. С. 3742. [Donina S.A., Petukhova G.D., Korenkov D.A., Grigorieva E.P., Kuznetsova S.A., Losev I.V.,Rudenko L.G., Naykhin A.N. Local Antibody Immune Responses in Influenza Patients and Persons Vaccinated with Seasonal, Pre-pandemic, and Pandemic Live Attenuated Influenza Vaccines. Voprosy virusologii = Problems of Virology, 2013, Vol. 58, no. 3, pp. 37-42. (In Russ.)]

2. Найхин А.Н., Денисов Г.М., Исмагулов А.Т., Топурия Н.В., Платонов В.Г., Царицына И.М., Иванников Ю.Г. Формирование, длительность сохранения и защитная роль антигемагглютининов к ранее циркулировавшим вирусам гриппа А // Вопросы вирусологии, 1980. No 4. С. 408-412. [Naykhin A.N., Denisov G.M., Ismagulov A.T., Topuriia N.V., Platonov V.G. Formation, persistence period and protective role of antihemagglutinins to earlier circulating influenza A viruses. Voprosy virusologii = Problems of Virology 1980, no. 4, pp. 408-412. (In Russ.)]

3. Найхин А.Н., Денисов Г.М., Иванников Ю.Г., Лисок Т.П., Олейникова Е.В., Царицына И.М. Итоги изучения коллективного иммунитета к вирусу гриппа А(Н1N1) в 1976-1980 гг. // Вопросы вирусологии, 1981. No 5. С. 553-557. [Naykhin A.N., Denisov G.M., Ivannikov Yu.G., Lisok T.P., Oleшnikova E.V. Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980. Voprosy virusologii = Problems of Virology, 1981, no. 5, pp. 553-557. (In Russ.)]

4. Найхин А.Н., Чиркова Т.В., Петухова Г.Д., Кореньков Д.А., Донина С.А., Руденко Л.Г. Стимуляция гомоигетерологичной Т-клеточной иммунологической памяти уволонтеров, привитых живой реассортантной гриппозной вакциной типа А(Н5N2) // Вопросы вирусологии, 2012. Т. 57, No 1. С. 38-42. [Naykhin A.N., Chirkova T.V., Petukhova G.D., Korenkov D.A., Donina S.A., Rudenko L.G. Stimulation of homoand heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine. Voprosy virusologii = Problems of Virology, 2012, Vol. 57, no. 1, pp. 38-42. (In Russ.)]

5. Найхин А.Н. Гетеросубтипический иммунитет к вирусам гриппа А: эпидемиологические данные, вовлеченность разных иммунологических факторов, вакцинация // Вопросы вирусологии, 2012. Т. 57, No 3. С. 4-9. [Naykhin A.N. Heterosubtypic immunity to influenza A viruses: epidemiological data, involvement of different immunological factors, vaccination. Voprosy virusologii = Problems of Virology, 2012, Vol. 57, no. 3, pp. 4-9. (In Russ.)]

6. Найхин А.Н., Донина С.А., Петухова Г.Д., Кореньков Д.А., Дорошенко Е.М., Григорьева Е.П., Суворова М.А., Руденко Л.Г. Гуморальный иклеточный иммунный ответ улюдей квирусу гриппа А/ Калифорния/07/2009(Н1N1)pdm2009 // Вопросы вирусологии, 2013. Т. 58, No 2. С. 38-42. [[Naykhin A.N., Donina S.A., Petuhova G.D., Korenkov D.A., Doroshenko E.M., Grigorieva E.P., Suvorova M.A., Rudenko L.G. Humoral and Cell-mediated Immune Responses in Humans to the A/California/ 07/ 2009 (H1N1) Virus, A(H1N1) pdm2009. Voprosy virusologii = Problems of Virology, 2013, Vol. 58, no. 2, pp. 38-42. (In Russ.)]

7. Bartlett E.J., Hennessey M., Skiadopoulos M.N., Schmidt A.C., Collins P.L., Murphy B.R., Pickles R.J. .Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium . J. Virol., 2008, Vol. 82, no. 16, pp. 8059-8070.

8. Belshe R.B., Gruber W.C., Mendelman P.M., Mehta H.B., Mahmood K., Reisinger K., Treanor J., Zangwill K., Hayden F.G., Bernstein D.I., Kotloff K., King J., Piedra P.A.,Block S.L., Yan L., Wolff M. Correlates of immune protection induced by live attenuated cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis., 2000, Vol. 181, no. 3, pp. 1133-1137.

9. Chirkova T.V., Naykhin A.N., Petukhova G.D., Korenkov D.A., Donina S.A., Mironov A.N., Rudenko L.G. Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A(H5N2) vaccine. Clinical and vaccine Immunol., 2011, Vol. 18, no. 10, pp. 1710-1718.

10. Karron R.A., Callahan K., Luke C., Thumar B., McAuliffe J., Schappell E., Joseph T., Coelingh K., Jin H., Kemble G., Murphy B.R., Subbarao K. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. J. Infect. Dis., 2009, Vol.199, no. 5, pp. 711-716.

11. Karron R.A., Talaat K., Luke C., Callahan K., Thumar B., Dilorenzo S., McAuliffe J., Schappell E., Suguitan A., Mills K., Chen G., Lamirande E., Coelingh K., Jin H., Murphy B.R., Kemble G., Subbarao K. Evaluation of two live attenuated cold-adapted H5N1 influenza vaccines in healthy adults. Vaccine. 2009, Vol. 27, no. 36, pp. 4953-4960.

12. Meijer A., Bosman A., van de Kamp E.E., Wilbrink B., van Beest Holle Man R., Koopmans M. Measurement of antibodies to avian influenza virus A(H7N7) in human by hemagglutination inhibition test. Virol. Methods, 2006, Vol. 132, pp. 113-120.

13. Murphy B.K., Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral. Immunol., 2002, Vol. 15, pp. 295-323.

14. Myers K.P., Setterquist S.F., Capuano A.W., Cray G.C. Infection due to 3 avian influenza subtypes in United States veterinarian. Clin. Infect. Dis., 2007, Vol. 45, pp. 4-9.

15. Nguyen-Van-Tam J.S., Nair P., Acheson P., Baker A., Barker M., Bracebridge S., Croft J., Ellis J., Gelletlie R., Gent N., Ibbotson S., Joseph C., Mahgoub H., Monk P., Reghitt T.W., Sundkvist T., Sellwood C., Simpson J., Smith J., Watson J.M., Zambon M., Lightfoot N. Outreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunetivitis. Euro Surveill, 2006, Vol. 11, F 0605042.

16. Petukhova G., Korenkov D., Chirkova T., Donina S., Rudenko L., Naykhin A. Band T-cell memory eliciated by seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cell using trogocytosis based method. Influenza and other resp. viruses., 2012, Vol. 6, no. 2, pp. 1-8.

17. Rowe T., Abernathy R.A., Hu-Primmer J. Detection of antibody to avian influenza A(H5N1) virus in human serum by using a combination of serologic assay. J. Clin. Microbiol., 1999, Vol. 37, pp. 937-943.

18. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T-cell subsets: function, generation and maintenance. Annu. Rev. Immunol., 2004, Vol. 22, pp. 745-763.

19. Shinya K., Ebina M., Yamada S., Kasai N., Kawaoka Y. Avian flu: Influenza virus receptors in the human airway. Nature, 2006, Vol. 440 (7083), pp. 435-436.

20. Sridhar S., Begom Sh., Bermingham A., Hoschler K., Adumson W., Carman W., Bean T., Barelay W., Deek J.J., Lalvani A. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med., 2013, Vol. 19, pp. 1305-1313.

21. Talaat K.R., Karron R.A., Luke C.J., Thumar B., McMahon B.A., Chen G.L., Lamirande E.W., Jin H., Coelingh K.L., Kemble G., Subbarao K. An open label phase I trial of live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine, 2011, Vol. 29, no. 17, pp. 3144-3148.

22. Talaat K.R., Karron R.A., Callahan K.A., Luke C.J., DiLorenzo S.C., Chen G.L., Lamirande E.W., Jin H., Coelingh K.L., Murphy B.R., Kemble G., Subbarao K. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine, 2009, Vol. 27, no. 28, pp. 3744-3753.

23. Talaat K.R., Karron R.A., Liang P.H., McMahon B.A., Luke C.J., Thumar B., Chen G.L., Min J.Y., Lamirande E.W., Jin H., Coelingh K.L., Kemble G.W., Subbarao K. An open-label Phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza and other resp. viruses., 2013, Vol. 7, no. 1, pp. 66-73.

24. Talaat K.R., Luke C.J., Khurana S., Manischewitz J., King L.R., McMahon B.A., Karron R.A., Lewis K.D., Qin J., Follmann D.A., Golding H., Neuzil K.M.,Subbarao K. A live attenuated influenza A(H5N1) vaccine induse long-term immunity in the absence of primary antibody response. J. Infect. Dis., 2014, Vol. 209, pp. 1860-1869.

25. Treanor J.J., Cambell J.D., Zangwill K.M., Rowe T., Wolff M. Safety and immunogenity of an inactivated subvirion influenza A(H5N1) vaccine. N. Engl. J. Med., 2006, Vol. 354, pp. 1343-1351.

26. Tweed S.A., Skowronski D.M., David S.T., Larder A., Petric M., Lees W., Li Y., Katz J., Krajden M., Tellier R., Halpert C., Hirst M., Astell C., Lawrence D., Mak A. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis., 2004, Vol. 10, pp. 2196-2199.

27. Update: influenza A(H3N2) transmission and guidelines – five states, 2011 Morb. Mort. Weekly Rep. January 6. 2012/60(51). pp. 1741-1744.

28. Who global action plan vaccine supple for influenza vaccine. 2006, Geneva, Belgium. WHO/IVB/06.13. WHO/ODS/EPR/GIP/2006.1.

29. (http:www.who.int/csr/disease/avianinfluenza/country/cases.table2008.03.18 /en/indexhtml)